Literature DB >> 18187937

Clinical report of three cases of acute radiation sickness from a (60)Co radiation accident in Henan Province in China.

Qiang Liu1, Bo Jiang, Li-Ping Jiang, Ying Wu, Xiao-Guang Wang, Feng-Ling Zhao, Bao-Hua Fu, Turai Istvan, Enhai Jiang.   

Abstract

On 26 April 1999, three persons were accidentally exposed by high dose (60)Co irradiation. They suffered from severe (one case) or moderate (two cases) hemopoietic form of acute radiation sickness (ARS). As part of the comprehensive treatment, strict reverse isolation and granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy were applied. All the patients recovered after an appropriate treatment for 83 days. In our experience, the correct diagnosis and effective treatment at an early stage proved to be helpful to the patients in pulling out from the critical stage of acute radiation sickness. To avoid menstruation by the female patient just in the critical stage, we modified her menstruation cycle by testosterone. In our view, GM-CSF should be given as early as possible with enough dosage for promoting early hematological reconstruction. The experience obtained from the medical management of these patients is valuable for the treatment of such patients in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187937     DOI: 10.1269/jrr.07071

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  16 in total

1.  Dose estimation by chromosome aberration analysis and micronucleus assays in victims accidentally exposed to (60)Co radiation.

Authors:  Q Liu; J Cao; Z Q Wang; Y S Bai; Y M Lü; Q L Huang; W Z Zhao; J Li; L P Jiang; W S Tang; B H Fu; F Y Fan
Journal:  Br J Radiol       Date:  2009-04-14       Impact factor: 3.039

2.  A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management.

Authors:  Ann M Farese; Melanie V Cohen; Barry P Katz; Cassandra P Smith; William Jackson; Daniel M Cohen; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

Review 3.  First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

4.  Mitigation of ionizing radiation-induced bone marrow suppression by p38 inhibition and G-CSF administration.

Authors:  Deguan Li; Yueying Wang; Hongying Wu; Lu Lu; Heng Zhang; Jianhui Chang; Zhibin Zhai; Junling Zhang; Yong Wang; Daohong Zhou; Aimin Meng
Journal:  J Radiat Res       Date:  2011-10-05       Impact factor: 2.724

5.  The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation.

Authors:  Thomas J MacVittie; Alexander Bennett; Catherine Booth; Michael Garofalo; Gregory Tudor; Amanda Ward; Terez Shea-Donohue; Daniel Gelfond; Emylee McFarland; William Jackson; Wei Lu; Ann M Farese
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

6.  The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependent.

Authors:  Ann M Farese; Cassandra R Brown; Cassandra P Smith; Allison M Gibbs; Barry P Katz; Cynthia S Johnson; Karl L Prado; Thomas J MacVittie
Journal:  Health Phys       Date:  2014-01       Impact factor: 1.316

7.  The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.

Authors:  Thomas J MacVittie; Alexander W Bennett; Ann M Farese; Cheryl Taylor-Howell; Cassandra P Smith; Allison M Gibbs; Karl Prado; William Jackson
Journal:  Health Phys       Date:  2015-11       Impact factor: 2.922

8.  Acute radiation syndrome (ARS) - treatment of the reduced host defense.

Authors:  Lars Heslet; Christiane Bay; Steen Nepper-Christensen
Journal:  Int J Gen Med       Date:  2012-01-31

Review 9.  Acute radiation syndrome caused by accidental radiation exposure - therapeutic principles.

Authors:  Harald Dörr; Viktor Meineke
Journal:  BMC Med       Date:  2011-11-25       Impact factor: 8.775

Review 10.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.